Rafael de Llorens
- Molecular Biology top 5%
- Oncology top 5%
- Immunology top 5%
- Organic Chemistry top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Rosa PeracaulaPauline M. RuddSílvia BarrabésAriadna SarratsClaudi M. CuchilloMarie‐Hélène Le DuRosa Núria AleixandreEsther Llop
- Topics
- Glycosylation and Glycoproteins Research (19 papers)HER2/EGFR in Cancer Research (9 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)
- Cited by
- OncologyMolecular BiologyImmunology
- Partner nations
- SpainUnited StatesIreland
In The Last Decade
Rafael de Llorens
61 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 1.7k
- Oncology 690
- Immunology 475
- Organic Chemistry 369
- Radiology, Nuclear Medicine and Imaging 316
Countries citing papers authored by Rafael de Llorens
This map shows the geographic impact of Rafael de Llorens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael de Llorens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael de Llorens more than expected).
Fields of papers citing papers by Rafael de Llorens
This network shows the impact of papers produced by Rafael de Llorens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael de Llorens. The network helps show where Rafael de Llorens may publish in the future.
Co-authorship network of co-authors of Rafael de Llorens
This figure shows the co-authorship network connecting the top 25 collaborators of Rafael de Llorens. A scholar is included among the top collaborators of Rafael de Llorens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael de Llorens. Rafael de Llorens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 36 | |
| 3 | 45 | |
| 4 | 14 | |
| 5 | 29 | |
| 6 | 47 | |
| 7 | 33 | |
| 8 | 74 | |
| 9 | 49 | |
| 10 | 46 | |
| 11 | 73 | |
| 12 | 34 | |
| 13 | 33 | |
| 14 | 2 | |
| 15 | 23 | |
| 16 | 24 | |
| 17 | 26 | |
| 18 | 50 | |
| 19 | 31 | |
| 20 | 13 |
About Rafael de Llorens
Rafael de Llorens is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 61 papers that have together received 2.4k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (19 papers), HER2/EGFR in Cancer Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Oncology (690 citations), Molecular Biology (1.7k citations) and Immunology (475 citations). Rafael de Llorens has collaborated with scholars based in Spain, United States and Ireland. Frequent co-authors include Rosa Peracaula, Pauline M. Rudd, Sílvia Barrabés, Ariadna Sarrats, Claudi M. Cuchillo, Marie‐Hélène Le Du, Rosa Núria Aleixandre, Esther Llop, Manel Ramírez and Radka Saldova. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.